Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Regenerative Medicine Market Revenue Worth $39,012 Million by 2030: P&S Intelligence

Published

on

 

Over 17.9 million people die of cardiovascular diseases (CVDs) and 9.6 million of cancer each year, says the World Health Organization (WHO). With the mortality rate increasing every year, the global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030.

This is because regenerative medicine is focused on repairing and recreating the tissues and cells destroyed by such diseases. In this regard, the regenerative medicine market is being driven by the rising geriatric population, as the elderly are more prone to chronic diseases than younger people. From 703 million in 2019, the number of people aged 65 and above around the world is set to reach 1.5 billion in 2050, as per the United Nations (UN).

Key Findings of Global Regenerative Medicine Market

  • Demand for regenerative medicine rising for COVID treatment
  • Mounting chronic disease burden strongest market growth driver
  • Regenerative medicine majorly used to treat musculoskeletal diseases
  • Emerging economies offering market players vast growth opportunities
  • Highest adoption of regenerative medicine witnessed in North America
  • Market fragmented due to existence of numerous key companies

Get the Sample Copy of this Report at @ https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market/report-sample

The COVID-19 pandemic initially hurt the regenerative medicine market growth prospects, as most of the non-essential hospital departments were shut down and much of the staff was redirected to COVID care. However, the race to find a novel treatment for the infection has led to a massive increase in the demand for regenerative medicine, especially cell-based therapies, across the globe.

In the past, the regenerative medicine market was dominated by the cell therapy category, based on type. Due to the havoc being wreaked by the COVID-19 pandemic, the number of clinical trials involving cell therapies as a potential treatment has risen manifold in the past few months.

The musculoskeletal category, under the application segment of the regenerative medicine market, is predicted to witness the fastest growth in the coming years. With the rising geriatric population, the prevalence of orthopedic diseases is increasing. Since such diseases often result in the wastage of the muscle and bone, regenerative medicine is proving essential for patients to live a normal life, by helping restore the bone and muscle density.

Browse detailed report with COVID-19 impact analysis on Regenerative Medicine Market Research Report: By Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Application (Musculoskeletal, Wound Care, Oncology, Dental, Ocular) – Global Industry Analysis and Demand Forecast to 2030 @  https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market

In the years to come, the highest CAGR in the regenerative medicine market will be seen in the Asia-Pacific (APAC) region. Economic growth, surging private and public funding in medical research, rising incidence of chronic diseases, increasing population of the elderly, and growing medical tourism industry are driving the market in regional countries.

Make enquiry about this report at @ https://www.psmarketresearch.com/send-enquiry?enquiry-url=regenerative-medicine-market

The most-significant companies in the global regenerative medicine market are 3M Company, Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet Holdings Inc., Amgen Inc., Novartis AG, Allergan plc, Organogenesis Holdings Inc., MiMedx Group Inc., Misonix Inc., Vericel Corporation, Takeda Pharmaceutical Company Limited, and Medtronic plc.

Artificial Intelligence

HER HIGHNESS SHEIKHA MOZA FORMALLY LAUNCHES QATAR PRECISION HEALTH INSTITUTE

Published

on

her-highness-sheikha-moza-formally-launches-qatar-precision-health-institute

Institute builds on 10 years of genomics research to address the under-representation of the Arab genome and unravel a more representative map of the human race
DOHA, Qatar, May 1, 2024 /PRNewswire/ — Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation, officially launched the Qatar Precision Health Institute, a national body aimed at leveraging the country’s advanced genomics research to accelerate personalized healthcare – leading to more precise treatments and improved health outcomes for people in the Arab world and beyond.

 
 
The Qatar Precision Health Institute builds on the groundbreaking work of Qatar Biobank and Qatar Genome Programme, uniting the efforts of Qatar Foundation’s research institutes to provide insights that reveal the effects of lifestyle, environment, and genetics on the Arab population.
Her Highness, Sheikha Moza bint Nasser, spoke at the formal launch event, emphasizing the importance of raising public awareness on the benefits of precision health. She said:
“I am proud that Qatar was the first country in the region to establish a population-based genome program, and has played a pioneering role in ensuring that Arab genomes are included in global genomic databases. Qatar’s efforts have led to faster and more accurate diagnoses of multiple diseases for people from the region. QPHI is building on those successes and taking our knowledge forward to implement clinical solutions that will lead to a healthier future not only for our citizens but for people around the world.”
Qatar Foundation’s work in the field of precision health led to the creation of the Qatari genome catalog, comprising more than 88 million variants, 24 million of which had never been reported previously in international databases.
Dr. Said Ismail, Acting President of QPHI, said:
“The Middle East is home to more than 400 million people, and is one of the world’s oldest inhabited regions, yet it is the most underrepresented in genome sequencing, as over 95% of available genome data comes from Western Europe and North America. Through research and clinical trials conducted at QPHI, we aim to improve the representation of Arab genomes in these datasets, empowering scientists to unravel the complete map of genomes that define the allelic spectrum of the human race, including Africa, East and Southeast Asia.”
QPHI will advance the study of the Arab genome through recruiting Qataris and long-time residents in large numbers, analyzing their biological samples, as well as information about their health and lifestyle. In doing so, it will make vital data accessible for researchers across the region and the world. Partnerships with leading global genomics institutes, including The Global Alliance for Genomics and Health, as well as the Health Institutes of Turkey will ensuring the transferability of discoveries, and strengthen genomics research on a global scale.
To date, Qatar Genome Programme has sequenced the genomes of over 40,000 Qataris or long-term Qatar residents, generating a wealth of data that has helped to inform diagnoses and treatments that have saved lives.
Through the use of precision medicine, a great number of diseases can be detected early, or avoided altogether. Interventions such as rapid genetic screening for heart patients has led to targeted treatment and a reduction in the number of days patients need to stay in hospital, while mandatory newborn screening through heel prick tests screens for over 80 disorders, giving doctors and parents the ability to detect treatable diseases before clinical presentation.
By seamlessly integrating cutting-edge research with clinical applications, QPHI will equip healthcare providers with the means to provide personalized treatment and elevate the standard of care while cementing Qatar’s position as a frontrunner in precision medicine on the global stage.
For more about Qatar Foundation, please visit qf.org.qa.
For more about QPHI, please visit qphi.org.qa
Photo: https://mma.prnewswire.com/media/2401712/Qatar_Foundation.jpg

View original content:https://www.prnewswire.co.uk/news-releases/her-highness-sheikha-moza-formally-launches-qatar-precision-health-institute-302132869.html

Continue Reading

Artificial Intelligence

ION LookOut named “Most Innovative Trade Surveillance Solution” at A-Team Innovation Awards 2024

Published

on

ion-lookout-named-“most-innovative-trade-surveillance-solution”-at-a-team-innovation-awards-2024

LONDON, May 1, 2024 /PRNewswire/ — ION, a global leader in trading and workflow automation software, high-value analytics and insights, and strategic consulting to financial institutions, central banks, governments, and corporates, announces that ION LookOut has been named “Most Innovative Trade Surveillance Solution” at the A-Team Innovation Awards 2024. 

The A-Team Innovation Awards recognize innovative projects and teams across the vendor and practitioner communities that leverage new and emerging technologies to deliver cutting-edge solutions for financial institutions in capital markets. The awards focus on data management, trading technology, ESG, and regtech suppliers whose contributions are advancing these areas.
ION LookOut, developed by LIST – an ION company, is a multi-asset trade surveillance solution used across multiple jurisdictions. Machine Learning for Alarm Classification (MLAC), ION LookOut’s AI-based assistant, helps compliance teams classify multiple alerts, reducing time and effort, and improving efficiency. MLAC optimizes alert management by learning from the past behavior of compliance officers. It helps reduce the workload of compliance officers while raising alarms for the necessary level of tracking activity. The automatic closure of low-profile alerts further streamlines the process, saving time.
“We are thrilled with ION LookOut’s win at the A-Team Innovation Awards 2024. The recognition reflects ION’s dedication to delivering high-value solutions that address our customers’ evolving needs,” said Alvise Insalaco, Chief Executive Officer: LIST.
“It’s an honor to have ION LookOut recognized for its innovative trade surveillance solution,” said Mirko Marcadella, Chief Product and Marketing Officer: LIST. “This award is a testament to ION’s unwavering commitment to push the boundaries of innovation and deliver solutions that empower our customers.”
Angela Wilbraham, CEO at A-Team Group and 4th annual A-Team Innovation Awards 2024 host, commented, “Many congratulations to ION for winning the Most Innovative Trade Surveillance Solution award in recognition of their achievement in delivering high levels of innovation to financial institutions. They should be deservedly proud of this accomplishment.”
ION LookOut was also named Best Solution for Record Retention at the RegTech Insight Awards APAC 2024 earlier this year, further demonstrating ION’s consistent track record of delivering award-winning products.
About ION
ION provides mission-critical trading and workflow automation software, high-value analytics and insights, and strategic consulting to financial institutions, central banks, governments, and corporates. Our solutions and services simplify complex processes, boost efficiency, and enable better decision-making. We build long-term partnerships with our clients, helping transform their businesses for sustained success through continuous innovation. For more information, visit https://iongroup.com/ 
About ION Markets
ION Markets provides transformative technology and solutions to financial institutions dealing in asset management, cleared derivatives, equities, fixed income, foreign exchange, and secured funding. Our award-winning end-to-end solutions simplify clients’ operations by automating the full trade lifecycle, providing tools to manage risk, and maximizing access to liquidity, while giving real-time access to critical information required for timely operational decisions and execution on a global scale. For more information, visit https://iongroup.com/markets/ 
About LIST
An ION company, LIST is a leading financial technology provider to the global trading community, including trading venues, market makers, brokers, asset managers, risk managers, and compliance officers. LIST’s innovative turnkey products and delivery, driven by customers’ needs, play a key role in supporting successful business growth in today’s volatile times. Continuous innovation and client partnerships around the globe have built trust and reliance on LIST’sunique real-time and data analytics capabilities. For more information, visit https://www.list-group.com/.
About A-Team Innovation Awards 2024
The A-Team Innovation Awards celebrate innovative projects and teams across the vendor and practitioner communities that make use of new and emerging technologies to deliver high-value solutions for financial institutions in capital markets, with a specific focus on data management, trading technology, ESG and regtech suppliers. For more information, visit https://a-teaminsight.com/awards/a-team-innovation-awards/
All product and company names herein may be trademarks of their registered owners.

View original content:https://www.prnewswire.co.uk/news-releases/ion-lookout-named-most-innovative-trade-surveillance-solution-at-a-team-innovation-awards-2024-302131767.html

Continue Reading

Artificial Intelligence

Open ECX announces partnership with Medius to offer enhanced AP automation capabilities

Published

on

open-ecx-announces-partnership-with-medius-to-offer-enhanced-ap-automation-capabilities

MANCHESTER, England, May 1, 2024 /PRNewswire/ — Following its recent launch into the channel market, leading e-trading solutions and Accounts Payable (AP) automation software provider, Open ECX, has announced a new partnership with Medius to provide their enhanced suite of advanced AP automation solutions. Open ECX’s statement reconciliation functionality together with Medius’s AP automation and fraud detection offerings offer organisations the ability to automate time consuming, error prone manual processes.

The collaboration will see Open ECX’s statement reconciliation functionality providing a true end to end automation for businesses looking to enhance their Accounts Payable (AP) automation and compliance levels.
Matt Rhodus, VP of Business Development & Strategic Initiatives at Medius, commented: “The partnership with Open ECX fills a void in our product offering with a statement matching and reconciliation solution that integrates with Medius’s AP automation platform. The expertise that the Open ECX team has in industries like construction means that customers get even more operational efficiencies in their financial operations.”
Open ECX is a leading provider of integrated business solutions, including e-trading, statement reconciliation and AP automation, and a pioneer in the P2P space. Its suite of products are designed to enhance operational efficiency and streamline AP processes through seamless integration, automation and innovative technologies, and are compatible with most finance systems used across a multitude of industries and use cases.
Charles Robinson, CCO, Open ECX commented: “At a time when businesses are demanding much more from their finance automation solutions, we’re delighted to be partnering with Medius. Our evolving suite of products have been designed to help finance leaders automate all transactions, while integrating seamlessly into their existing systems and processes. When combined with the power of Medius’ solutions, the partnership will add huge value to customers who are looking to take advantage of holistic, automated AP systems.”
For press information, interviews and images please contact the Open ECX press office:Sara Donnelly: [email protected]  T: 07495 090385Clare Wall: [email protected]  T: 07974 161127
For more information visit:  www.openecx.com 
For more information from Medius, please contact:Francesca Cahill (EMEA) at Fight or Flight, [email protected] / [email protected] +44 330 133 0985
For more information visit: www.medius.com 
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/medius/r/open-ecx-announces-partnership-with-medius-to-offer-enhanced-ap-automation-capabilities,c3971365
 

View original content:https://www.prnewswire.co.uk/news-releases/open-ecx-announces-partnership-with-medius-to-offer-enhanced-ap-automation-capabilities-302132854.html

Continue Reading

Trending